Digitala Vetenskapliga Arkivet

Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Protocol for in vivo immune cell analysis in subcutaneous murine tumor models using advanced flow cytometry
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Immunology, Genetics and Pathology, Cancer precision medicine.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Immunology, Genetics and Pathology, Vascular Biology.ORCID iD: 0000-0002-6541-9852
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Surgical Sciences, Otolaryngology and Head and Neck Surgery. Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Immunology, Genetics and Pathology, Cancer precision medicine.ORCID iD: 0000-0002-1509-2142
2025 (English)In: STAR Protocols, ISSN 2666-1667, Vol. 6, no 1, article id 103505Article in journal (Refereed) Published
Abstract [en]

Here, we present a protocol for guiding tissue preparation and flow cytometric analysis in subcutaneous murine tumor models and secondary lymphoid organs. We describe steps for dissociating tumors, spleens, and lymph nodes to obtain single-cell suspensions. We then detail procedures for immune cell staining and analysis and gating strategies including the use of fluorescence-minus-one controls (FMOs). This approach provides valuable insights into the impact of cancer therapies on the tumor and systemic immune response.

Place, publisher, year, edition, pages
Elsevier, 2025. Vol. 6, no 1, article id 103505
National Category
Cancer and Oncology Immunology in the medical area Cell and Molecular Biology
Identifiers
URN: urn:nbn:se:uu:diva-549499DOI: 10.1016/j.xpro.2024.103505ISI: 001399511100001PubMedID: 39823235Scopus ID: 2-s2.0-85215111881OAI: oai:DiVA.org:uu-549499DiVA, id: diva2:1939430
Funder
Swedish Cancer Society, 21 0371 FESwedish Cancer Society, 243787 PjSwedish Childhood Cancer Foundation, FT2023-0023Swedish Childhood Cancer Foundation, PR2023-0111Erik, Karin och Gösta Selanders FoundationÅke Wiberg FoundationSwedish Childhood Cancer Foundation, TJ2022-0016Available from: 2025-02-21 Created: 2025-02-21 Last updated: 2025-02-21Bibliographically approved

Open Access in DiVA

fulltext(11385 kB)116 downloads
File information
File name FULLTEXT01.pdfFile size 11385 kBChecksum SHA-512
74fcd29c043287dff8ea49c21f8ccbb57de3cf92d84cfa70c62450b85098603d7296d5fcfe4a3c3fdbce83d93b09088d7127791936ed37e48f3f99a76a22be95
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMedScopus

Search in DiVA

By author/editor
Ingelshed, KatrineMelssen, Marit M.Spiegelberg, Diana
By organisation
Cancer precision medicineVascular BiologyOtolaryngology and Head and Neck Surgery
Cancer and OncologyImmunology in the medical areaCell and Molecular Biology

Search outside of DiVA

GoogleGoogle Scholar
Total: 116 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 257 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf